Importer of Controlled Substances; Notice of Application, 1812-1813 [2010-504]
Download as PDF
<![CDATA[
1812
Federal Register / Vol. 75, No. 8 / Wednesday, January 13, 2010 / Notices
United States Department of Justice,
Justice Management Division, Policy
and Planning Staff, Patrick Henry
Building, Suite 1600, 601 D Street, NW.,
Washington, DC 20530.
Dated: January 7, 2010.
Lynn Bryant,
Department Clearance Officer, PRA, United
States Department of Justice.
[FR Doc. 2010–408 Filed 1–12–10; 8:45 am]
BILLING CODE 4410–18–P
DEPARTMENT OF JUSTICE
Office of Justice Programs
[OMB Number 1121–0235]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
srobinson on DSKHWCL6B1PROD with NOTICES
ACTION: 60-Day Notice of Information
Collection Under Review: Extension of
a currently approved collection;
Bulletproof Vest Partnership.
The Department of Justice, Office of
Justice Programs, Bureau of Justice
Assistance, will be submitting the
following information collection request
for review and clearance in accordance
with the Paperwork Reduction Act of
1995. This proposed information
collection is published to obtain
comments from the public and affected
agencies. Comments are encouraged and
will be accepted for ‘‘sixty days’’ until
March 15, 2010. If you have additional
comments, suggestions, or need a copy
of the proposed information collection
instrument with instructions or
additional information, please contact
M. Berry at 202–353–8643 or 1–866–
859–2687, by e-mail at
M.A.Berry@ojp.usdoj.gov or by postal
mail at the Bureau of Justice Assistance,
Office of Justice Programs, U.S.
Department of Justice, 810 7th Street,
NW., Washington, DC 20531.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility.
(2) Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used.
VerDate Nov<24>2008
16:51 Jan 12, 2010
Jkt 220001
(3) Enhance the quality, utility, and
clarity of the information to be
collected.
(4) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of This Information
(1) Type of information collection:
Extension of a currently approved
collection.
(2) The title of the form/collection:
Bulletproof Vest Partnership.
(3) The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form Number: None, Bureau of Justice
Assistance, Office of Justice Programs,
Department of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract. Primary: State, Local, or Tribal
Governments. Other: None. Abstract:
The Bureau of Justice Assistance (BJA)
collects this information as part of the
application for federal assistance
process under the Bulletproof Vest
Partnership (BVP) Program. The
purpose of this program is to help
protect the lives of law enforcement
officers by helping states and units of
local and tribal governments equip their
officers with armor vests. An applicant
may request funds to help purchase one
vest per officer per fiscal year. Federal
payment covers up to 50 percent of each
jurisdiction’s total costs. BJA uses the
information collected to review,
approve, and make awards to
jurisdictions in accordance with
programmatic and statutory
requirements.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond/reply: There are approximately
4,500 respondents who will respond
approximately once per year, for a total
of 4,500 responses. Each response will
require approximately 1 hour to
complete.
(6) An estimate of the total public
burden (in hours) associated with the
collection: The total annual public
burden hours for this information
collection is estimated to be 5,000
hours: 5,000 × 60 minutes per
application = 300,000 minutes/by 60
minutes per hour = 5,000 hours.
If additional information is required,
please contact, Lynn Bryant, Clearance
Officer, United States Department of
Justice, Justice Management Division,
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
Policy and Planning Staff, Patrick Henry
Building, Suite 1600, 601 D Street, NW.,
Washington, DC 20530.
Dated: January 7, 2010.
Lynn Bryant,
Department Clearance Officer, PRA, United
States Department of Justice.
[FR Doc. 2010–409 Filed 1–12–10; 8:45 am]
BILLING CODE 4410–18–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to Title 21 Code of Federal
Regulations 1301.34(a), this is notice
that on November 6, 2009, Mallinckrodt
Inc., 3600 North Second Street, St.
Louis, Missouri 63147, made
application by renewal to the Drug
Enforcement Administration (DEA) for
registration as an importer of the basic
classes of controlled substances listed in
schedule II:
Drug
Phenylacetone (8501) ..................
Coca Leaves (9040) .....................
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
Schedule
II
II
II
II
The company plans to import the
listed controlled substances for the
manufacture of controlled substances in
bulk for distribution to its customers.
No comments, objections, or requests
for any hearings will be accepted on any
application for registration or reregistration to import crude opium,
poppy straw, concentrate of poppy
straw or coca leaves. As explained in
the Correction to Notice of Application
pertaining to Rhodes Technologies, 72
FR 3417 (2007), comments and requests
for hearings on applications to import
narcotic raw material are not
appropriate.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic classes of controlled
substances listed in schedule I or II,
which fall under the authority of section
1002(a)(2)(B) of the Act (21 U.S.C.
952(a)(2)(B)) may, in the circumstances
set forth in 21 U.S.C. 958(i), file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such comments or objections
should be addressed, in quintuplicate,
to the Drug Enforcement
E:\FR\FM\13JAN1.SGM
13JAN1
Federal Register / Vol. 75, No. 8 / Wednesday, January 13, 2010 / Notices
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, VA 22152; and must be
filed no later than February 12, 2010.
This procedure is to be conducted
simultaneously with and independent
of the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745), all applicants for
registration to import a basic class of
any controlled substances in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: January 6, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–504 Filed 1–12–10; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Manufacturer of Controlled
Substances Notice of Registration
srobinson on DSKHWCL6B1PROD with NOTICES
Schedule
VerDate Nov<24>2008
16:51 Jan 12, 2010
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Jkt 220001
Alfentanil (9737) ...........................
Remifentanil (9739) ......................
Sufentanil (9740) ..........................
Fentanyl (9801) ............................
II
II
II
II
The company plans on manufacturing
the listed controlled substances in bulk
for sale to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of Cody
Laboratories to manufacture the listed
basic classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated Cody
Laboratories to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
[FR Doc. 2010–511 Filed 1–12–10; 8:45 am]
By Notice dated August 28, 2009, and
published in the Federal Register on
September 8, 2009, (74 FR 46231), Cody
Laboratories, 601 Yellowstone Avenue,
Cody, Wyoming 82414, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the basic classes of controlled
substances listed in schedules I and II:
Dihydromorphine (9145) ...............
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Phenylacetone (8501) ..................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Diphenoxylate (9170) ...................
Ecgonine (9180) ...........................
Hydrocodone (9193) .....................
Meperidine (9230) ........................
Methadone (9250) ........................
Morphine (9300) ...........................
Oxymorphone (9652) ...................
Schedule
Dated: January 6, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Drug Enforcement Administration
Drug
Drug
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated August 28, 2009, and
published in the Federal Register on
September 8, 2009, (74 FR 46231),
Chemic Laboratories, Inc., 480 Neponset
Street, Building 7, Canton,
Massachusetts 02021, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of Cocaine (9041),
a basic class of controlled substance
listed in schedule II.
The company plans to manufacture
small quantities of the above listed
controlled substance for distribution to
its customers for the purpose of
research.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Chemic Laboratories to manufacture the
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
1813
listed basic class of controlled substance
is consistent with the public interest at
this time. DEA has investigated Chemic
Laboratories to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
Dated: January 6, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–515 Filed 1–12–10; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated September 14, 2009,
and published in the Federal Register
on September 18, 2009, (74 FR 47962),
GE Healthcare, 3350 North Ridge
Avenue, Arlington Heights, Illinois
60004–1412, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of Cocaine (9041),
a basic class of controlled substance
listed in schedule II.
The company plans to manufacture a
radioactive product used in diagnostic
imaging in the diagnosis of Parkinson’s
Disease and for manufacture in bulk for
investigational new drug (IND)
submission and clinical trials.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of GE
Healthcare to manufacture the listed
basic class of controlled substance is
consistent with the public interest at
this time. DEA has investigated GE
Healthcare to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
E:\FR\FM\13JAN1.SGM
13JAN1
]]>Agencies
[Federal Register Volume 75, Number 8 (Wednesday, January 13, 2010)]
[Notices]
[Pages 1812-1813]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-504]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this
is notice that on November 6, 2009, Mallinckrodt Inc., 3600 North
Second Street, St. Louis, Missouri 63147, made application by renewal
to the Drug Enforcement Administration (DEA) for registration as an
importer of the basic classes of controlled substances listed in
schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Phenylacetone (8501)....................... II
Coca Leaves (9040)......................... II
Opium, raw (9600).......................... II
Poppy Straw Concentrate (9670)............. II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
the manufacture of controlled substances in bulk for distribution to
its customers.
No comments, objections, or requests for any hearings will be
accepted on any application for registration or re-registration to
import crude opium, poppy straw, concentrate of poppy straw or coca
leaves. As explained in the Correction to Notice of Application
pertaining to Rhodes Technologies, 72 FR 3417 (2007), comments and
requests for hearings on applications to import narcotic raw material
are not appropriate.
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic classes of controlled
substances listed in schedule I or II, which fall under the authority
of section 1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may, in
the circumstances set forth in 21 U.S.C. 958(i), file comments or
objections to the issuance of the proposed registration and may, at the
same time, file a written request for a hearing on such application
pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR
1316.47.
Any such comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement
[[Page 1813]]
Administration, Office of Diversion Control, Federal Register
Representative (ODL), 8701 Morrissette Drive, Springfield, VA 22152;
and must be filed no later than February 12, 2010.
This procedure is to be conducted simultaneously with and
independent of the procedures described in 21 CFR 1301.34(b), (c), (d),
(e), and (f). As noted in a previous notice published in the Federal
Register on September 23, 1975, (40 FR 43745), all applicants for
registration to import a basic class of any controlled substances in
schedule I or II are, and will continue to be, required to demonstrate
to the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, that the requirements for such
registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR
1301.34(b), (c), (d), (e), and (f) are satisfied.
Dated: January 6, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-504 Filed 1-12-10; 8:45 am]
BILLING CODE 4410-09-P
